Massachusetts Financial Services CO Vanda Pharmaceuticals Inc. Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

A detailed history of Massachusetts Financial Services CO transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 184,181 shares of VNDA stock, worth $920,905. This represents 0.0% of its overall portfolio holdings.

Number of Shares

184,181

Holding current value

$920,905

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.61 - $6.34 $849,074 - $1.17 Million	184,181 New	184,181 $863,000
Q1 2024 May 14, 2024	SELL	$3.47 - $4.61 $1,051 - $1,396	-303 Reduced 0.22%	136,340 $560,000
Q4 2023 Feb 08, 2024	SELL	$3.38 - $4.58 $14,588 - $19,767	-4,316 Reduced 3.06%	136,643 $576,000
Q3 2023 Nov 08, 2023	SELL	$4.28 - $6.57 $23,116 - $35,484	-5,401 Reduced 3.69%	140,959 $608,000
Q2 2023 Aug 09, 2023	SELL	$5.9 - $6.95 $20,349 - $23,970	-3,449 Reduced 2.3%	146,360 $964,000
Q1 2023 May 10, 2023	SELL	$6.18 - $7.99 $26,166 - $33,829	-4,234 Reduced 2.75%	149,809 $1.02 Million
Q4 2022 Feb 13, 2023	BUY	$6.87 - $10.96 $22,403 - $35,740	3,261 Added 2.16%	154,043 $1.14 Million
Q3 2022 Nov 09, 2022	SELL	$9.44 - $11.76 $12,980 - $16,170	-1,375 Reduced 0.9%	150,782 $1.49 Million
Q2 2022 Aug 09, 2022	BUY	$9.31 - $11.84 $7,150 - $9,093	768 Added 0.51%	152,157 $1.66 Million
Q1 2022 May 11, 2022	BUY	$10.84 - $16.55 $16,845 - $25,718	1,554 Added 1.04%	151,389 $1.71 Million
Q4 2021 Feb 10, 2022	SELL	$15.69 - $21.14 $47,619 - $64,159	-3,035 Reduced 1.99%	149,835 $2.35 Million
Q3 2021 Nov 10, 2021	SELL	$15.35 - $21.27 $30,792 - $42,667	-2,006 Reduced 1.3%	152,870 $2.62 Million
Q2 2021 Aug 13, 2021	BUY	$15.71 - $21.51 $1.12 Million - $1.53 Million	71,101 Added 84.87%	154,876 $3.33 Million
Q1 2021 May 13, 2021	SELL	$13.42 - $20.28 $193,100 - $291,808	-14,389 Reduced 14.66%	83,775 $1.26 Million
Q4 2020 Feb 12, 2021	SELL	$9.77 - $13.81 $9,642 - $13,630	-987 Reduced 1.0%	98,164 $1.29 Million
Q3 2020 Nov 12, 2020	BUY	$9.32 - $12.02 $924,087 - $1.19 Million	99,151 New	99,151 $958,000
Q1 2019 May 13, 2019	SELL	$17.59 - $31.05 $1.03 Million - $1.83 Million	-58,810 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$18.97 - $31.47 $87,015 - $144,352	4,587 Added 8.46%	58,810 $1.54 Million
Q3 2018 Oct 25, 2018	BUY	$18.25 - $23.0 $989,569 - $1.25 Million	54,223 New	54,223 $1.25 Million
Q2 2018 Jul 30, 2018	SELL	$13.95 - $19.15 $180,750 - $248,126	-12,957 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$14.05 - $20.2 $2,810 - $4,040	200 Added 1.57%	12,957 $218,000
Q4 2017 Feb 14, 2018	BUY	$12.85 - $18.1 $23,001 - $32,399	1,790 Added 16.32%	12,757 $194,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $168,891 - $206,727	10,967	10,967 $196,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.3M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $283M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Vanda Pharmaceuticals Inc. Transaction History